

The global ctDNA Detection market size was valued at US$ 1544 million in 2024 and is forecast to a readjusted size of USD 4148 million by 2031 with a CAGR of 15.3% during review period.
Circulating Tumor DNA (ctDNA) detection is a molecular diagnostic technique that identifies tumor-specific genetic mutations in the DNA fragments released into the bloodstream by cancer cells. It can provide insights into cancer progression and treatment response.
This report is a detailed and comprehensive analysis for global ctDNA Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global ctDNA Detection market size and forecasts, in consumption value ($ Million), 2020-2031
Global ctDNA Detection market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global ctDNA Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global ctDNA Detection market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for ctDNA Detection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global ctDNA Detection market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Rad, Roche, Biocartis, Qiagen, Guardant Health, Johnson & Johnson, Amoy Diagnostics, Annaroad Gene Technology, Burning Rock Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
ctDNA Detection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Independent Detection
Joint Detection
Market segment by Application
Hospital
Third-party Testing Agency
Market segment by players, this report covers
Bio-Rad
Roche
Biocartis
Qiagen
Guardant Health
Johnson & Johnson
Amoy Diagnostics
Annaroad Gene Technology
Burning Rock Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe ctDNA Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of ctDNA Detection, with revenue, gross margin, and global market share of ctDNA Detection from 2020 to 2025.
Chapter 3, the ctDNA Detection competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and ctDNA Detection market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of ctDNA Detection.
Chapter 13, to describe ctDNA Detection research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of ctDNA Detection by Type
1.3.1 Overview: Global ctDNA Detection Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global ctDNA Detection Consumption Value Market Share by Type in 2024
1.3.3 Independent Detection
1.3.4 Joint Detection
1.4 Global ctDNA Detection Market by Application
1.4.1 Overview: Global ctDNA Detection Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Third-party Testing Agency
1.5 Global ctDNA Detection Market Size & Forecast
1.6 Global ctDNA Detection Market Size and Forecast by Region
1.6.1 Global ctDNA Detection Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global ctDNA Detection Market Size by Region, (2020-2031)
1.6.3 North America ctDNA Detection Market Size and Prospect (2020-2031)
1.6.4 Europe ctDNA Detection Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific ctDNA Detection Market Size and Prospect (2020-2031)
1.6.6 South America ctDNA Detection Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa ctDNA Detection Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Bio-Rad
2.1.1 Bio-Rad Details
2.1.2 Bio-Rad Major Business
2.1.3 Bio-Rad ctDNA Detection Product and Solutions
2.1.4 Bio-Rad ctDNA Detection Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Bio-Rad Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche ctDNA Detection Product and Solutions
2.2.4 Roche ctDNA Detection Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Roche Recent Developments and Future Plans
2.3 Biocartis
2.3.1 Biocartis Details
2.3.2 Biocartis Major Business
2.3.3 Biocartis ctDNA Detection Product and Solutions
2.3.4 Biocartis ctDNA Detection Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Biocartis Recent Developments and Future Plans
2.4 Qiagen
2.4.1 Qiagen Details
2.4.2 Qiagen Major Business
2.4.3 Qiagen ctDNA Detection Product and Solutions
2.4.4 Qiagen ctDNA Detection Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Qiagen Recent Developments and Future Plans
2.5 Guardant Health
2.5.1 Guardant Health Details
2.5.2 Guardant Health Major Business
2.5.3 Guardant Health ctDNA Detection Product and Solutions
2.5.4 Guardant Health ctDNA Detection Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Guardant Health Recent Developments and Future Plans
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson ctDNA Detection Product and Solutions
2.6.4 Johnson & Johnson ctDNA Detection Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Johnson & Johnson Recent Developments and Future Plans
2.7 Amoy Diagnostics
2.7.1 Amoy Diagnostics Details
2.7.2 Amoy Diagnostics Major Business
2.7.3 Amoy Diagnostics ctDNA Detection Product and Solutions
2.7.4 Amoy Diagnostics ctDNA Detection Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Amoy Diagnostics Recent Developments and Future Plans
2.8 Annaroad Gene Technology
2.8.1 Annaroad Gene Technology Details
2.8.2 Annaroad Gene Technology Major Business
2.8.3 Annaroad Gene Technology ctDNA Detection Product and Solutions
2.8.4 Annaroad Gene Technology ctDNA Detection Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Annaroad Gene Technology Recent Developments and Future Plans
2.9 Burning Rock Biotech
2.9.1 Burning Rock Biotech Details
2.9.2 Burning Rock Biotech Major Business
2.9.3 Burning Rock Biotech ctDNA Detection Product and Solutions
2.9.4 Burning Rock Biotech ctDNA Detection Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Burning Rock Biotech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global ctDNA Detection Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of ctDNA Detection by Company Revenue
3.2.2 Top 3 ctDNA Detection Players Market Share in 2024
3.2.3 Top 6 ctDNA Detection Players Market Share in 2024
3.3 ctDNA Detection Market: Overall Company Footprint Analysis
3.3.1 ctDNA Detection Market: Region Footprint
3.3.2 ctDNA Detection Market: Company Product Type Footprint
3.3.3 ctDNA Detection Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global ctDNA Detection Consumption Value and Market Share by Type (2020-2025)
4.2 Global ctDNA Detection Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global ctDNA Detection Consumption Value Market Share by Application (2020-2025)
5.2 Global ctDNA Detection Market Forecast by Application (2026-2031)
6 North America
6.1 North America ctDNA Detection Consumption Value by Type (2020-2031)
6.2 North America ctDNA Detection Market Size by Application (2020-2031)
6.3 North America ctDNA Detection Market Size by Country
6.3.1 North America ctDNA Detection Consumption Value by Country (2020-2031)
6.3.2 United States ctDNA Detection Market Size and Forecast (2020-2031)
6.3.3 Canada ctDNA Detection Market Size and Forecast (2020-2031)
6.3.4 Mexico ctDNA Detection Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe ctDNA Detection Consumption Value by Type (2020-2031)
7.2 Europe ctDNA Detection Consumption Value by Application (2020-2031)
7.3 Europe ctDNA Detection Market Size by Country
7.3.1 Europe ctDNA Detection Consumption Value by Country (2020-2031)
7.3.2 Germany ctDNA Detection Market Size and Forecast (2020-2031)
7.3.3 France ctDNA Detection Market Size and Forecast (2020-2031)
7.3.4 United Kingdom ctDNA Detection Market Size and Forecast (2020-2031)
7.3.5 Russia ctDNA Detection Market Size and Forecast (2020-2031)
7.3.6 Italy ctDNA Detection Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific ctDNA Detection Consumption Value by Type (2020-2031)
8.2 Asia-Pacific ctDNA Detection Consumption Value by Application (2020-2031)
8.3 Asia-Pacific ctDNA Detection Market Size by Region
8.3.1 Asia-Pacific ctDNA Detection Consumption Value by Region (2020-2031)
8.3.2 China ctDNA Detection Market Size and Forecast (2020-2031)
8.3.3 Japan ctDNA Detection Market Size and Forecast (2020-2031)
8.3.4 South Korea ctDNA Detection Market Size and Forecast (2020-2031)
8.3.5 India ctDNA Detection Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia ctDNA Detection Market Size and Forecast (2020-2031)
8.3.7 Australia ctDNA Detection Market Size and Forecast (2020-2031)
9 South America
9.1 South America ctDNA Detection Consumption Value by Type (2020-2031)
9.2 South America ctDNA Detection Consumption Value by Application (2020-2031)
9.3 South America ctDNA Detection Market Size by Country
9.3.1 South America ctDNA Detection Consumption Value by Country (2020-2031)
9.3.2 Brazil ctDNA Detection Market Size and Forecast (2020-2031)
9.3.3 Argentina ctDNA Detection Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa ctDNA Detection Consumption Value by Type (2020-2031)
10.2 Middle East & Africa ctDNA Detection Consumption Value by Application (2020-2031)
10.3 Middle East & Africa ctDNA Detection Market Size by Country
10.3.1 Middle East & Africa ctDNA Detection Consumption Value by Country (2020-2031)
10.3.2 Turkey ctDNA Detection Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia ctDNA Detection Market Size and Forecast (2020-2031)
10.3.4 UAE ctDNA Detection Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 ctDNA Detection Market Drivers
11.2 ctDNA Detection Market Restraints
11.3 ctDNA Detection Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 ctDNA Detection Industry Chain
12.2 ctDNA Detection Upstream Analysis
12.3 ctDNA Detection Midstream Analysis
12.4 ctDNA Detection Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Bio-Rad
Roche
Biocartis
Qiagen
Guardant Health
Johnson & Johnson
Amoy Diagnostics
Annaroad Gene Technology
Burning Rock Biotech
Ìý
Ìý
*If Applicable.